Dr. Agarwal’s crosses Rs. 2,000 crore revenue milestone in FY26
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Dr. Upadhyay brings over 25 years of global leadership experience across life sciences, regulated manufacturing, diagnostics, and research-led environments
Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
Subscribe To Our Newsletter & Stay Updated